CLDN5 and glioblastoma: In addition, results showed that down-regulation of claudin-5 in pathological BBB model significantly increased the transport of Ap-CSSO/DOX nanoparticles crossing the barrier (Figure 3(F)) and then for GBM cascade-targeting uptake (Figure 3(E)).